Who Owns Actinium Pharmaceuticals (Delaware) Stock?
NYSE: ATNMHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 17.31%
- Held by insiders
- 8.08%
- Institutional holders
- 56
- Institutions 17.3%
- Insiders 8.1%
- Public and other 74.6%
Who owns Actinium Pharmaceuticals (Delaware) stock?
Institutional investors own about 17.3% of Actinium Pharmaceuticals (Delaware)'s shares, spread across 56 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 8.08% of ATNM.
The largest institutional holders are Vanguard Capital Management LLC (3.94%), Compass Financial Management LLC (1.91%) and Millennium Management Llc (1.64%). Together, the top 10 institutions control 14.5% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their ATNM positions and 7 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ATNM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 1.24M | 3.94% | -1.4% |
| Compass Financial Management LLC | 600.23K | 1.91% | +100.0% |
| Millennium Management Llc | 514.58K | 1.64% | -8.9% |
| Acadian Asset Management. LLC | 496.29K | 1.58% | -17.4% |
| Blackrock Inc. | 395.90K | 1.26% | +6.7% |
| Renaissance Technologies, LLC | 380.49K | 1.21% | -19.3% |
| Geode Capital Management, LLC | 324.94K | 1.03% | -3.3% |
| Two Sigma Investments, LP | 259.18K | 0.82% | -23.1% |
| Gagnon Securities, LLC | 182.14K | 0.58% | -9.5% |
| Vanguard Fiduciary Trust Co | 161.53K | 0.51% | +0.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ATNM
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 918.56K | 2.92% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 315.37K | 1.00% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 159.77K | 0.51% |
| iShares Trust-iShares Micro-Cap ETF | 106.02K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 52.29K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 44.53K | 0.14% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 5.85K | 0.02% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 4.38K | 0.01% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 3.11K | 0.01% |
| ADVISORS' INNER CIRCLE III-Knights of Columbus U.S. All Cap Index Fund | 175 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Actinium Pharmaceuticals (Delaware)?
Vanguard Capital Management LLC is the largest institutional shareholder of ATNM, owning 3.94% of shares outstanding (1.24M shares) as of its latest 13F filing.
What percentage of Actinium Pharmaceuticals (Delaware) is owned by institutions?
Institutions own about 17.3% of ATNM shares and 18.8% of the public float.
How much of Actinium Pharmaceuticals (Delaware) do insiders own?
Insiders, such as officers and directors, own about 8.08% of ATNM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.